B) Our study consisted of two parts: 1) We analyzed liquid biopsies and measured serum S100A8/A9 concentrations at two different time points via ELISA (MRP8/14) in a cohort of 43 stage III and IV melanoma patients treated with ICIs. The gene discussed is S100A8; the disease is melanoma.